ClinicalTrials.gg
Active, not recruitingNCT06094088RHYMEUpdated Nov 12, 2026

Researching Heat and Yoga for Mood Enhancement

An interventional study of Heated Yoga and Non-Heated Yoga in Depression, sponsored by Massachusetts General Hospital. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Nov 12, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 163 studies in Depression by Massachusetts General Hospital — 24 open to participants now, 33 under way, none of them phase 3. Depression · Massachusetts General Hospital.

Planned enrollment
34th of 153
120 · median 60
Started
2025
with 11 others
No phase
100 of 163
19 open now
Primary completion
2026-12
later than 3 of 32 live
Registered
137th of 163
by date

Among the 163 studies in Depression by Massachusetts General Hospital, this one is the 34th largest by planned enrollment of the 153 interventional ones that give a count, is one of 12 that started in 2025, is one of 100 with no phase, reaches primary completion later than 3 of the 32 other live ones, and was the 137th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

24 of the 163 studies in Depression by Massachusetts General Hospital are open now, in 4 countries. Recruiting first, the newest first:

19 more — sign in →

By country, each count listing its studies:

All 24 open studies →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 163 studies in Depression by Massachusetts General Hospital, or all of them as a file.
02

Study summary

This study will examine how doing heated yoga or non-heated yoga affects depression.

Read the detailed description

The purpose of this study is to investigate the effects of heated and non-heated yoga on depressive symptoms. Previous research trials using heated and non-heated yoga interventions have shown promising results for reducing depression and its related outcomes. However, no studies have directly compared the effects of heated vs. non-heated yoga for depression. The researchers aim to address this gap by conducting a non-inferiority trial comparing heated yoga and non-heated yoga interventions to improve depressive symptoms. Both the heated and non-heated yoga interventions will be conducted in-person by certified yoga instructors. Eligible participants will be adults who do not regularly practice yoga or meditation and are experiencing moderate levels of depression. Assessments will be conducted at baseline, mid-treatment, post-treatment, and follow-up using a secure data capture system.

03

Conditions studied

  • Depression

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. adults (18-65 years old)
  2. able to provide consent
  3. are able to read and understand English
  4. PHQ-9 score between 10-20, indicating moderate but not severe depressive symptom severity (27)
  5. Must have filled out the waiver for the community-based yoga studio prior to enrolling in the study.

Exclusion criteria

Exclusion Criteria:

  1. have had a bone fracture or joint surgery in the past 6 months
  2. not able to walk freely or without difficulty
  3. have severe heart failure or lung disease
  4. participants endorse an item on the revised Physical Activity Readiness Questionnaire (PAR-Q+) and do not have approval from their treating physician (we will check in with treating physician in the event that participants endorse any item on the PAR-Q+)
  5. participants must have a physician responsible for their medical care
  6. are pregnant or planning to become pregnant
  7. no more than 6 yoga classes in the past 6 months
  8. have active suicidal thinking (i.e., PHQ-9 item 9 ≥1 and a positive response to C-SSRS screener items 3, 4, 5, or 6)
  9. report manic symptoms (Altman Self-Rating Mania Scale score ≥ 6 (28))
  10. are on medications that make dehydration more likely (e.g., lithium, antipsychotics, insulin-dependent)
  11. active eating disorders or substance use disorders within the past 12 months
  12. antidepressant or psychiatric medications that are initiated less than 8 weeks or a dose change less than 4 weeks prior to screening visit
  13. psychotherapy that has been initiated within the past 3 months
  14. willingness to keep psychiatric medications and psychotherapy stable throughout the course of the study
  15. psychiatric hospitalization within the past year
  16. diagnosed with any neurological disorders that would impact participation or make participation unsafe
  17. are currently in any active ketamine, ECT, or TMS
  18. are unable to follow the study procedures (e.g., not able to travel to the heated or non-heated yoga studios)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Heated Yoga

    The heated (i.e., \~105°F with 40% humidity) yoga will be 90 minutes long and consist of 26 Hatha yoga postures and 2 breathing exercises. The class starts with standing postures for approximately 45-50 minutes, followed by a 2-minute savasana (or corpse pose on the floor) and the remainder of the 90-minute class is completed on the mat. All yoga teachers will be heated yoga certified.

    Behavioral: Heated Yoga

  • Active comparator
    Non-heated Yoga

    The non-heated (i.e., room temperature \< 80°F) yoga will be 90 minutes long and consist of 26 Hatha yoga postures and 2 breathing exercises. The class starts with standing postures for approximately 45-50 minutes, followed by a 2-minute savasana (or corpse pose on the floor) and the remainder of the 90-minute class is completed on the mat. All yoga teachers will be heated yoga certified.

    Behavioral: Non-Heated Yoga

Interventions

  • BehavioralHeated Yoga

    Heated yoga described in arm/group description

  • BehavioralNon-Heated Yoga

    Non-heated yoga described in arm/group description

06

What researchers measure

Primary outcomes

  1. Patient Health Questionnaire-9 (PHQ-9)

    This measure is a 9-item self-report questionnaire that is widely used to assess depression symptom severity. PHQ-9 scores range from 0 to 27. A PHQ-9 score ≥10 has a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively.

    Time frame: Weeks 0, 4, 8, and 20

Secondary outcomes

  1. The World Health Organization-5 Well-Being Index (WHO-5)

    This measure is a 5-item self-report questionnaire with positively-worded statements related to positive mood, vitality, and general interest over the prior two weeks. The WHO-5 is reliable, has shown strong construct validity as a measure of general quality of life, and is sensitive to change. The WHO-5 has a score range of 0 to 25, with higher scores indicating better wellbeing.

    Time frame: Weeks 0, 4, 8, and 20

  2. Patient Reported Outcomes Measurement Information System-29 (PROMIS-29)

    This measure has seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, social functioning, sleep disturbance). The scale includes four items per domain, each scored from 1 to 5. The scale also includes one question at the end about pain intensity, which is scored from 0 to 10. The possible score for each domain ranges from 4 to 20 and the total possible score for the entire measure ranges from 28 to150. Higher scores indicate poorer outcomes.

    Time frame: Weeks 0, 4, 8, and 20

  3. Ruminative Responses Scale (RRS)

    This measure is a 22-item questionnaire, commonly used to assess rumination. Items are scored from 1 to 4, the scale has a possible range of 22 to 88, and higher scores indicate poorer outcomes (i.e. higher rumination).

    Time frame: Weeks 0, 4, 8, and 20

  4. The Five Facet Mindfulness Questionnaire (FFMQ-15)

    A self-report instrument that measures mindfulness; derived from factor analytic study of five independent mindfulness questionnaires. The scale contains 39 items, split into five domains (Observing, Describing, Acting with Awareness, Nonjudging, Nonreactivity), with each item being rated from 1 to 5. Some items are reverse coded. Total FFMQ scores range from 39 to 195, with greater scores indicating better outcomes (i.e. greater mindfulness).

    Time frame: Weeks 0, 4, 8, and 20

07

Study locations

2 sites
  • Orange Door Collaborative
    Cambridge, Massachusetts 02139, United States
  • Breathe Yoga Studio
    Cambridge, Massachusetts 02142, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Dec 2026, 17 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 17 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

Primary completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Dec 2026, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2023
First posted
Oct 23, 2023
StartActual
Jul 1, 2025
Primary completionEst.
Dec 2026was Sep 2026
CompletionEst.
Dec 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 1, 2026→Dec 2026
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Sep 1, 2026→Dec 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06094088
Collaborators
Tiny Blue Dot Foundation
Responsible party
Maren Nyer (Clinical Psychologist, Massachusetts General Hospital) — Principal investigator
First posted
Oct 23, 2023
Start date
Jul 1, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion